This Article Full Text Full Text (PDF) Alert me when this article is cited Alert me if a correction is posted Services Similar articles in this journal Similar articles in PubMed Alert me to new issues of the journal Download to citation manager Reprints and Permissions Copyright Information Books from ASM Press MicrobeWorld Citing Articles Citing Articles via HighWire Citing Articles via Google Scholar Google Scholar Articles by Kobayashi, M. Articles by Hasegawa, M. Search for Related Content PubMed PubMed Citation Articles by Kobayashi, M. Articles by Hasegawa, M.

 Previous Article  |  Next Article 

Journal of Virology, February 2003, p. 2607-2614, Vol. 77, No. 4
0022-538X/03/$08.00+0     DOI: 10.1128/JVI.77.4.2607-2614.2003
Copyright © 2003, American Society for Microbiology. All Rights Reserved.

Pseudotyped Lentivirus Vectors Derived from Simian Immunodeficiency Virus SIVagm with Envelope Glycoproteins from Paramyxovirus

DNAVEC Research Inc., Tsukuba, Ibaraki 305-0856, Japan

Received 26 July 2002/ Accepted 14 November 2002

We describe the development of novel lentivirus vectors based on simian immunodeficiency virus from African green monkey (SIVagm) pseudotyped with Sendai virus (SeV) envelope glycoproteins. SeV fusion (F) and hemagglutinin-neuraminidase (HN) proteins were successfully incorporated into the SIVagm-based vector by truncation of the cytoplasmic tail of the F protein and by addition of the cytoplasmic tail of SIVagm transmembrane envelope protein to the N terminus of the HN protein. As with the vesicular stomatitis virus G glycoprotein-pseudotyped vector, the mutant SeV F- and HN-pseudotyped SIVagm vector was able to transduce various types of animal and human cell lines. Furthermore, the vector was able to transduce an enhanced green fluorescent protein reporter gene into polarized epithelial cells of rat trachea from the apical and basolateral sides. Therefore, SeV F- and HN-pseudotyped SIVagm vectors have considerable potential for effective use in gene therapy for various therapies, including respiratory diseases.

This article has been cited by other articles:

• Tomei, A. A., Choe, M. M., Swartz, M. A. (2008). Effects of dynamic compression on lentiviral transduction in an in vitro airway wall model. Am. J. Physiol. Lung Cell. Mol. Physiol. 294: L79-L86 [Abstract] [Full Text]  
• Claus, C., Hofmann, J., Uberla, K., Liebert, U. G. (2006). Rubella virus pseudotypes and a cell-cell fusion assay as tools for functional analysis of the rubella virus E2 and E1 envelope glycoproteins.. J. Gen. Virol. 87: 3029-3037 [Abstract] [Full Text]  
• Springfeld, C., von Messling, V., Tidona, C. A., Darai, G., Cattaneo, R. (2005). Envelope Targeting: Hemagglutinin Attachment Specificity Rather than Fusion Protein Cleavage-Activation Restricts Tupaia Paramyxovirus Tropism. J. Virol. 79: 10155-10163 [Abstract] [Full Text]  
• Pickles, R. J. (2004). Physical and Biological Barriers to Viral Vector-mediated Delivery of Genes to the Airway Epithelium. Proc Am Thorac Soc 1: 302-308 [Abstract] [Full Text]  
• Zhang, H., Wang, G., Li, J., Nie, Y., Shi, X., Lian, G., Wang, W., Yin, X., Zhao, Y., Qu, X., Ding, M., Deng, H. (2004). Identification of an Antigenic Determinant on the S2 Domain of the Severe Acute Respiratory Syndrome Coronavirus Spike Glycoprotein Capable of Inducing Neutralizing Antibodies. J. Virol. 78: 6938-6945 [Abstract] [Full Text]